Skyline Medical Inc.

EDGAR

113 filing records in this dataset, filed from 2009-11-25 to 2026-08-14. Reported financial figures are available; chart coverage varies by period.

Watchlist
Cash and cash equivalents
21.9 million USD Source
Exact value

21900000 USD

Long-term debt including current maturities
0 USD Source
Exact value

0 USD

Shares outstanding
11.4 million shares Source
Exact value

11384940 shares

Reported share-count change

18.63% · 1.79 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 9596737 shares · 2025-06-30· Source
  • 11384940 shares · 2026-06-30· Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 6 of 11 periods available· newest 2025-12-31
  • Net income: 6 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 7 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 7 of 11 periods available· newest 2025-12-31
  • Total assets: 7 of 11 periods available· newest 2025-12-31
  • Total liabilities: 7 of 11 periods available· newest 2025-12-31
  • Current assets: 7 of 11 periods available· newest 2025-12-31
  • Current liabilities: 7 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2021-12-31
  • Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 220.43 million

    Prior period

    −USD 12.66 million

    –

    Current period

    −USD 233.1 million

    –

    Exact inputs and evidence

    -233095203 − -12664388 = -220430815 USD

    -12664388 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -233095203 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 227,045

    Prior period

    −USD 10.1 million

    –

    Current period

    −USD 9.88 million

    –

    Exact inputs and evidence

    -9876039 − -10103084 = 227045 USD

    -10103084 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -9876039 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -100%

    Prior period

    USD 9,510

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    -0 − 9510 = -9510 USD

    9510 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -0 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2015 2015-01-01 – 2015-12-31
Unavailable Not reported for this period.
−USD 7.49 million
Exact value

Exact value: -7487293 USD

2015-01-01 – 2015-12-31: -7487293 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 32,470
Exact value

Exact value: 32470 USD

2015-01-01 – 2015-12-31: 32470 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.52 million
Calculation and evidence

-7487293 − 32470 USD

Exact free cash flow: -7519763 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 25.88 million
Exact value

Exact value: -25884397 USD

2020-01-01 – 2020-12-31: -25884397 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.26 million
Exact value

Exact value: -12257732 USD

2020-01-01 – 2020-12-31: -12257732 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 298,379
Exact value

Exact value: 298379 USD

2020-01-01 – 2020-12-31: 298379 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.56 million
Calculation and evidence

-12257732 − 298379 USD

Exact free cash flow: -12556111 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 19.66 million
Exact value

Exact value: -19657174 USD

2021-01-01 – 2021-12-31: -19657174 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.21 million
Exact value

Exact value: -12208929 USD

2021-01-01 – 2021-12-31: -12208929 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 910,429
Exact value

Exact value: 910429 USD

2021-01-01 – 2021-12-31: 910429 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.12 million
Calculation and evidence

-12208929 − 910429 USD

Exact free cash flow: -13119358 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 25.74 million
Exact value

Exact value: -25737634 USD

2022-01-01 – 2022-12-31: -25737634 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.37 million
Exact value

Exact value: -12370800 USD

2022-01-01 – 2022-12-31: -12370800 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 419,869
Exact value

Exact value: 419869 USD

2022-01-01 – 2022-12-31: 419869 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.79 million
Calculation and evidence

-12370800 − 419869 USD

Exact free cash flow: -12790669 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 13.98 million
Exact value

Exact value: -13983967 USD

2023-01-01 – 2023-12-31: -13983967 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.78 million
Exact value

Exact value: -11784070 USD

2023-01-01 – 2023-12-31: -11784070 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 21,533
Exact value

Exact value: 21533 USD

2023-01-01 – 2023-12-31: 21533 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.81 million
Calculation and evidence

-11784070 − 21533 USD

Exact free cash flow: -11805603 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 12.66 million
Exact value

Exact value: -12664388 USD

2024-01-01 – 2024-12-31: -12664388 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.1 million
Exact value

Exact value: -10103084 USD

2024-01-01 – 2024-12-31: -10103084 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 9,510
Exact value

Exact value: 9510 USD

2024-01-01 – 2024-12-31: 9510 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.11 million
Calculation and evidence

-10103084 − 9510 USD

Exact free cash flow: -10112594 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 233.1 million
Exact value

Exact value: -233095203 USD

2025-01-01 – 2025-12-31: -233095203 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.88 million
Exact value

Exact value: -9876039 USD

2025-01-01 – 2025-12-31: -9876039 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: -0 USD

2025-01-01 – 2025-12-31: -0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.88 million
Calculation and evidence

-9876039 − -0 USD

Exact free cash flow: -9876039 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

113 filings · 3,852 latest values · 3,852 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001446159, 1446159, AGPU, POAI, SKLN, SKLND, aipt, bior, edgar:1446159, poai, skln

Also known as Axe Compute Inc, Axe Compute Inc., BioDrain Medical, Inc., Precision Therapeutics Inc., Predictive Oncology Inc., Skyline Medical Inc.